Entera Bio Ltd (ENTX) Social Stream
ENTERA BIO LTD (ENTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ENTX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-06 | 2 | $12 | $10 | $11 | $0.685 | 1505.84% |
| 2022-03-09 | 2 | $12 | $6 | $9.333 | $0.685 | 1262.48% |
| 2022-05-19 | 3 | $9 | $6 | $7 | $0.685 | 921.9% |
| 2022-07-19 | 3 | $9 | $5 | $6.666 | $0.685 | 873.14% |
| 2022-11-15 | 3 | $10 | $6 | $8.333 | $0.685 | 1116.5% |
| 2022-11-18 | 3 | $10 | $2 | $7 | $0.685 | 921.9% |
| 2023-04-04 | 2 | $10 | $2 | $7 | $0.685 | 921.9% |
| 2023-05-08 | 1 | $10 | $2 | $7 | $0.685 | 921.9% |
| 2023-09-11 | 1 | $10 | $2 | $6 | $0.685 | 775.91% |
| 2023-12-11 | 1 | $10 | $10 | $10 | $0.685 | 1359.85% |
The Trend in the Analyst Price Target
Over the past 28 months, ENTX's average price target has gone down $2.
Over the past 37 weeks, ENTX's average upside potential has been 825.92%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-28 | 2 | 10 | 2 | 7 | 1.063 | 558.51% |
| 2023-04-04 | 2 | 10 | 2 | 7 | 0.980 | 614.29% |
| 2023-05-08 | 1 | 10 | 2 | 7 | 0.880 | 695.45% |
| 2023-09-11 | 1 | 10 | 10 | 10 | 0.669 | 1394.77% |
| 2023-12-11 | 1 | 10 | 10 | 10 | 0.689 | 1351.38% |
ENTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 17 months, ENTX's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, ENTERA BIO LTD's upside potential (average analyst target price relative to current price) is greater than 1362.13% of them.
- In the context of all US stocks, ENTERA BIO LTD's number of analysts covering the stock is higher than 51.05% of them.
- In terms of how ENTERA BIO LTD fares relative to all US stocks, note that its average analyst price target is higher than 113.45% of that group.
- ENTERA BIO LTD's variance in analysts' estimates is lower than -867.59% of stocks in the micro market cap category.
In the Pharmaceutical Products industry, GENE, TARA, and TCON are the three stocks most similar to ENTERA BIO LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for ENTX? Use POWR Ratings for clearer insight into price direction.